NL8801171A - Methode voor het behandelen van nicotineverslaving en daarvoor bestemde preparaten. - Google Patents
Methode voor het behandelen van nicotineverslaving en daarvoor bestemde preparaten. Download PDFInfo
- Publication number
- NL8801171A NL8801171A NL8801171A NL8801171A NL8801171A NL 8801171 A NL8801171 A NL 8801171A NL 8801171 A NL8801171 A NL 8801171A NL 8801171 A NL8801171 A NL 8801171A NL 8801171 A NL8801171 A NL 8801171A
- Authority
- NL
- Netherlands
- Prior art keywords
- smoking
- dopamine receptor
- day
- bromocriptine
- receptor agonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4775387A | 1987-05-07 | 1987-05-07 | |
| US4775387 | 1987-05-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8801171A true NL8801171A (nl) | 1988-12-01 |
Family
ID=21950776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8801171A NL8801171A (nl) | 1987-05-07 | 1988-05-04 | Methode voor het behandelen van nicotineverslaving en daarvoor bestemde preparaten. |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS63287723A (enExample) |
| KR (1) | KR880013556A (enExample) |
| AU (1) | AU622614B2 (enExample) |
| CH (1) | CH675834A5 (enExample) |
| DE (1) | DE3814521A1 (enExample) |
| DK (1) | DK245388A (enExample) |
| FR (1) | FR2614789B1 (enExample) |
| GB (1) | GB2204240B (enExample) |
| IT (1) | IT1219564B (enExample) |
| NL (1) | NL8801171A (enExample) |
| PH (1) | PH25495A (enExample) |
| SE (1) | SE8801708L (enExample) |
| ZA (1) | ZA883237B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797405A (en) * | 1987-10-26 | 1989-01-10 | Eli Lilly And Company | Stabilized pergolide compositions |
| DE19626621A1 (de) * | 1996-07-02 | 1998-01-08 | Hexal Ag | Pflaster zur transdermalen Anwendung von Pergolid |
| US6623752B1 (en) | 1996-07-02 | 2003-09-23 | Hexal Ag | Patch for transdermal application for pergolid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR861128B (en) * | 1985-05-06 | 1986-08-26 | Sandoz Ag | New use of dopamine agonists |
| DE3722383A1 (de) * | 1986-07-14 | 1988-01-28 | Sandoz Ag | Neue verwendung von bromocriptin |
-
1988
- 1988-04-29 DE DE3814521A patent/DE3814521A1/de not_active Withdrawn
- 1988-05-02 FR FR888805957A patent/FR2614789B1/fr not_active Expired - Lifetime
- 1988-05-03 IT IT47906/88A patent/IT1219564B/it active
- 1988-05-04 CH CH1664/88A patent/CH675834A5/de not_active IP Right Cessation
- 1988-05-04 NL NL8801171A patent/NL8801171A/nl not_active Application Discontinuation
- 1988-05-04 GB GB8810509A patent/GB2204240B/en not_active Expired - Lifetime
- 1988-05-05 DK DK245388A patent/DK245388A/da not_active Application Discontinuation
- 1988-05-05 AU AU15605/88A patent/AU622614B2/en not_active Expired - Fee Related
- 1988-05-05 ZA ZA883237A patent/ZA883237B/xx unknown
- 1988-05-05 SE SE8801708A patent/SE8801708L/ not_active Application Discontinuation
- 1988-05-06 JP JP63109280A patent/JPS63287723A/ja active Pending
- 1988-05-06 PH PH36895A patent/PH25495A/en unknown
- 1988-05-06 KR KR1019880005250A patent/KR880013556A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| SE8801708L (sv) | 1988-11-08 |
| FR2614789B1 (fr) | 1991-10-18 |
| SE8801708D0 (sv) | 1988-05-05 |
| ZA883237B (en) | 1990-01-31 |
| KR880013556A (ko) | 1988-12-21 |
| DK245388D0 (da) | 1988-05-05 |
| DK245388A (da) | 1988-11-08 |
| GB8810509D0 (en) | 1988-06-08 |
| IT1219564B (it) | 1990-05-18 |
| AU1560588A (en) | 1988-11-10 |
| GB2204240A (en) | 1988-11-09 |
| CH675834A5 (enExample) | 1990-11-15 |
| GB2204240B (en) | 1991-04-24 |
| FR2614789A1 (fr) | 1988-11-10 |
| IT8847906A0 (it) | 1988-05-03 |
| PH25495A (en) | 1991-07-24 |
| DE3814521A1 (de) | 1988-11-17 |
| AU622614B2 (en) | 1992-04-16 |
| JPS63287723A (ja) | 1988-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4800204A (en) | Method of controlling tobacco use | |
| EP1315505B1 (en) | Pharmaceutical compositions for headache, migraine, nausea and emesis | |
| US20020019421A1 (en) | Compositions and therapy for substance addiction | |
| HU206042B (en) | Process for producing pharmaceutical compositions comprising indole-3-carboxylic acid-endo-8-methyl-8-azabicyclo/3.2.1./oct-3-yl ester and/or 1,2,3-9-tetrahydro-9-methyl-3-(2-methyl-1h-imidazol-1-yl)-methyl-4h-carbazol-4-one, with an activity preventing or reducing opiate-, alcohol- and nicotine-dependence | |
| Gourlay et al. | Antismoking products | |
| BG61829B1 (bg) | Използване на дифенилбутилпиперазинкарбоксамид при лечение насмущения, предизвикани от злоупотреба с вещества | |
| US20090130178A1 (en) | Formulation for decreasing tobacco, alcohol, drug or food consumption | |
| AU2001286178A1 (en) | Pharmaceutical compositions for headache, migraine, nausea and emesis | |
| US6166032A (en) | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use | |
| AU2002224525B2 (en) | Compositions for regulating desire for smoking | |
| WO1995007690A1 (en) | Composition and method for treating nicotine craving in smoking cessation | |
| PL196334B1 (pl) | Zastosowanie agonistów receptorów GABA B i ich farmaceutycznie dopuszczalnych pochodnych w terapii abstynencji nikotynowej u uzależnionych od nikotyny pacjentów | |
| NL8801171A (nl) | Methode voor het behandelen van nicotineverslaving en daarvoor bestemde preparaten. | |
| WO1990000896A1 (en) | USE OF BENZO(g)QUINOLINES IN TREATMENT OF NICOTINE ADDICTION | |
| US5414005A (en) | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation | |
| JP2002522388A (ja) | 性機能障害の治療のためのピリジノン | |
| HU206829B (en) | Process for producing pharmaceutical compositions containing buspirone against smoking and obesity | |
| US20020168403A1 (en) | Compositions and therapy for substance addiction | |
| EP1518554B1 (en) | Pharmaceutical composition for the treatment of hyperhomocysteinemia | |
| WO2016018178A1 (ru) | Комплексное антиникотиновое средство | |
| AU1045695A (en) | Use of lobeline for the treatment of nicotine withdrawal | |
| JPH07505367A (ja) | 喫煙停止におけるニコチン渇望の処置のための副交感神経作用剤とムスカリン性拮抗剤との配合 | |
| KOZLOWSKI | The determinants of tobacco use: cigarette smoking in the context of other forms of tobacco use | |
| WO1995028934A2 (en) | Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers | |
| WO2004080454A1 (en) | Composition comprising 5-hydroxytryptophan for reducing or alleviating the effects of nicotine withdrawal and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CNR | Transfer of rights (patent application after its laying open for public inspection) |
Free format text: MUELLER. PETER STERLING - |
|
| BV | The patent application has lapsed |